Newsroom

Newsroom

How does medical purpose drive regulatory requirements in EU clinical trials?

Blog
Read More

FedEx Express National Service Disruption: Severe Winter Weather

Blog
Read More

NeoGenomics Announces Chief Financial Officer Transition

Press Release
Read More

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release
Read More

RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease

Press Release
Read More

NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)

Press Release
Read More

Deep phenotyping and spatial immune contexture characterization through a combined multiplex immunofluorescence ( mIF ) approach

Literature
Read More

NeoGenomics Reports Third Quarter 2022 Results

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients